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Abstract
Oxidative stress plays an important role in neuronal injuries caused by cerebral ischemia. It is well established that free iron
increases significantly during ischemia and is responsible for oxidative damage in the brain. However, the mechanism of this
ischemia-induced increase in iron is not completely understood. In this report, the middle cerebral artery occlusion (MCAO)
rat model was performed and the mechanism of iron accumulation in cerebral ischemia-reperfusion was studied. The
expression of L-ferritin was significantly increased in the cerebral cortex, hippocampus, and striatum on the ischemic side,
whereas H-ferritin was reduced in the striatum and increased in the cerebral cortex and hippocampus. The expression level
of the iron-export protein ferroportin1 (FPN1) significantly decreased, while the expression of transferrin receptor 1 (TfR1)
was increased. In order to elucidate the mechanisms of FPN1 regulation, we studied the expression of the key regulator of
FPN1, hepcidin. We observed that the hepcidin level was significantly elevated in the ischemic side of the brain. Knockdown
hepcidin repressed the increasing of L-ferritin and decreasing of FPN1 invoked by ischemia-reperfusion. The results indicate
that hepcidin is an important contributor to iron overload in cerebral ischemia. Furthermore, our results demonstrated that
the levels of hypoxia-inducible factor-1a (HIF-1a) were significantly higher in the cerebral cortex, hippocampus and striatum
on the ischemic side; therefore, the HIF-1a-mediated TfR1 expression may be another contributor to the iron overload in the
ischemia-reperfusion brain.
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Introduction
Many mechanisms are involved in ischemia-induced brain
injuries, such as oxidative stress [1,2], increased intracellular
calcium concentration [3,4,5], inflammation [6,7], and elevated
excitatory amino acids [8]. Iron, the most abundant trace metal in
the brain, is also believed to play a critical role in neuronal injuries
caused by oxidative stress in ischemia, although the exact
mechanism is not understood. Increased levels of free iron and
ferritin have been observed in ischemic brain [9,10]. Free iron is a
major generator of reactive oxygen species, which are capable of
damaging biological molecules such as lipids, carbohydrates,
proteins, and nucleic acids [11,12]. Furthermore, during hypoxia,
free iron appears to accelerate intracellular free radical formation
and lipid peroxidation, causing subsequent neuronal injury and
death [13,14]. The damaging role of free iron in the ischemic
brain is underscored by the beneficial effects of the iron chelator
desferrioxamine (DFO) [13,15,16].
Under physiological conditions, cell iron levels are precisely
regulated. Ferritin, transferrin receptor (TfR) and ferroportin 1
(FPN1) play an important role in the management of iron
metabolism. Accumulated evidence suggests that the transferrin–
transferrin receptor (Tf–TfR) pathway might be the major route of
iron transport across the luminal membrane of the capillary
endothelium and iron uptake by nerve cells [17,18]. In ischemic
rat hearts, Tang et al [19] have reported that increased hypoxia
inducible factor 1 (HIF-1) expression promotes the expression of
TfR1 that leads to an increase in free iron. FPN1 [20], also known
as IREG1 [21] or MTP1 [22], is a newly discovered transmem-
brane iron export protein. It is known that FPN1 is expressed on
the basolateral surfaces of duodenal enterocytes and in macro-
phages, and plays a key role in iron transport across the basolateral
membrane of enterocytes and in iron export during erythrocyte-
iron recycling by macrophages [17]. Recent findings suggest that
FPN1 is also expressed in the brain and might play a role in iron
export from nerve cells [23,24]. Most recently, Li et al. have
shown that FPN1 mRNA expression was decreased in the cerebral
cortex and hippocampus in rats subjected to cerebral ischemia
[25]. However, the mechanisms responsible for increased free iron
in an ischemic brain remain poorly understood.
Hepcidin, also known as ‘liver expressed antimicrobial peptide’
(LEAP), is an iron regulatory hormone mainly produced by
hepatocytes in response to inflammatory stimuli, iron, and hypoxia
[26,27,28,29]. Functional studies have demonstrated that hepcidin
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complex and degradation of FPN1, thereby reducing cellular iron
efflux [30]. The 19-amino acid peptide hepcidin-binding domain
(HBD) of FPN1 has been identified by De Domenico et al. [31].
In the brain, iron homeostasis depends on both iron uptake by
the cells and iron export from the cells [17]. TfR1 and divalent
metal transporter 1 (DMT1) are important molecules responsible
for iron uptake. FPN1 is the sole known cellular iron exporter and
plays an important role in brain iron release. Recently, our
laboratory found that hepcidin is widely expressed in the murine
brain [32]. We further observed that, in the cerebral cortex, the
hippocampus, and the striatum, hepcidin mRNA levels increased
with aging. Injection of hepcidin into the lateral cerebral ventricle
resulted in decreased FPN1 protein levels in the cerebral cortex,
the hippocampus, and the striatum. Our results suggest that
regulation of brain iron efflux by hepcidin could play a role in the
control of brain iron metabolism. In the present study,
experiments were carried out to test the hypothesis that hepcidin
is involved in the iron overload in ischemia-reperfusion brain using
rat and mouse stroke models of middle cerebral artery occlusion
(MCAO). We also identified that increased TfR1 expression
induced by HIF-1a may be another contributor to the iron
overload in the ischemia-reperfusion brain.
Materials and Methods
Animals and experimental design
All procedures were carried out in accordance with the National
Institutes of Health Guide for the Care and Use of Laboratory
Animals, and were approved by the Animal Ethics Committee of
Hebei Normal University. Wistar rats weighing 230–250 g and
BALB/c mice weighing 20–25 g were given free access to food
and water and kept in a 12 h light/dark cycle at 22.061.0uC. All
rats and mice were allowed to adapt to their living conditions for at
least 3 days before surgery.
The focal cerebral ischemia-reperfusion model of rats [33] and
mice [34] was prepared according to a published method. Briefly,
Wistar rats and BALB/c mice were anesthetized with 10% chloral
hydrate (3.5 ml/kg, i.p.). After the left common carotid artery
(CCA) was exposed through a midline neck incision, the CCA,
external carotid artery (ECA), internal carotid artery (ICA) and
pterygopalatine artery (PPA) were carefully separated from the
adjacent tissue and vagus nerve. Then, two 5–0 silk sutures were
tied loosely around the mobilized ECA stump and PPA. A 4-cm
(for rats) and 2.5-cm (mice) length of fish wire (Beijing Sunbio
Biotech, Beijing, China) was inserted through the incision of CCA
into the ICA and thence into the circle of Willis, effectively
occluding the MCA. The silk sutures around the ECA and PPA
were lifted that is propitious to the suture reached to MCA. The
silk suture around the CCA stump was then tightened around the
intraluminal fish wire to prevent bleeding. The intraluminal
occluders were made of fish wire and the diameter of the tip was
0.28 mm for rats and 0.18 mm for mice. After 1 h of MCAO, the
fish wire was withdrawn from the ICA into the stump of the CCA
and the withdrawal was stopped as soon as resistance was felt. The
ischemic brain area starts the reperfusion. Then the animals were
returned to their cages after recovering from anesthesia and
allowed to survive for 24 h with free access to food and water.
The neurological score was assessed 24 h after reperfusion. The
signs of neurologic impairment were evaluated according to
Longa’s 5-point scoring system 1 h after reperfusion (0 indicates
no neurological symptoms; 1 indicates a failure to stretch the right
forepaw completely; 2 indicates circling toward right; 3 indicates
lateroversion toward the right when walking, and 4 indicates loss
of walking). The score of all of the animals in the experimental
group was 1, 2 or 3.
Lateral cerebral ventricle injections
Hepcidin siRNAs or negative control siRNAs (Invitrogen, San
Diego, CA) were suspended in RNase-free water to yield a
concentration of 200 pmol/mL. 2.5 mL siRNA was combined with
2.5 mL tranxin and incubated at room temperature (RT) for
15 min. Mice were anesthetized with pentobarbital (40 mg/kg)
and placed in a stereotactic device. Hepcidin or negative control
(sham) siRNAs were slowly injected into the right lateral cerebral
ventricle. Two hours later, the focal cerebral ischemia-reperfusion
model was prepared as described above.
Measurements of cerebral infarct
After neurological assessment, animals were sacrificed by
decapitation. Intact brains were isolated and cut into 5 coronal
sections. The brain slices were stained with 2,3,5-triphenyltetra-
zolium chloride (TTC) solution at 37uC for 30 min in the dark.
After staining, normal brain tissue appeared as red, the
circumjacent region of infarct as rose-pink, and the infarct region
as white. The infarct tissues (ischemia side) and the normal tissues
in the opposite side of the brain (control side) were collected for
detection.
Measurement of brain iron
The total iron in brain tissues was determined using Inductively
Coupled Plasma Mass Spectroscopy (ICP-MS, Thermo Fisher, X
Series, FL, USA). Before the experiments, all of the containers
were soaked with 15% nitric acid for 24 h, washed with deionized
water, and then rinsed with ultra-pure water before drying.
Approximately 20 mg of brain tissues was added to 1 ml ultra-
pure nitric acid (69.9–70.0%, J.T. Baker, USA) in Teflon digestion
tubes, digested in the microwave digestion system for 2 h at
100uC, and then 4 h at 200uC [35]. The totally digested samples
were diluted to 10 ml with ultra-pure water. Standard curves
ranging from 0 to 100 ppb were prepared by diluting iron
standard (1 mg iron/ml) with blanks prepared from homogeniza-
tion reagents in 0.2% nitric acid. Standards and digested samples
were read in triplicate by ICP-MS.
Measurement of ferritin iron
Lysates of brain tissues were incubated for 10 min, cooled on
ice, sonicated, and centrifuged at 12,000 rpm for 20 min, and the
supernatant was collected. Protein concentrations were measured
with a Nanodrop ND-1000 UV Spectrophotometer. A 200 mg
portion was used for immunoprecipitation (IP). Samples were
incubated at 4uC with a mixture of rabbit anti-H ferritin (Santa
Cruz Biotechnology, CA, USA) and anti-L ferritin (Epitomics, CA,
USA) antibodies for 3 h in order to precipitate the ferritins [36].
40 ml protein A/G agrose (Santa Cruz Biotechnology, CA, USA)
was added and incubated at 4uC for 12 h. The precipitate was
separated by centrifugation and washed with TBS-T (50 mM Tris
base, 150 mM NaCl, 0.1% SDS, 1% Triton X-100) buffer. Ultra-
pure nitric acid (1 ml) was added and digested in the microwave
digestion apparatus [37]. The total ferritin-bound iron was
determined by ICP-MS.
Reverse transcription (RT)-PCR
RNA was isolated from brain tissues by Trizol Reagent
(Invitrogen, CA, USA). RT-PCR using total RNA (2 mg) was
performed with the Revert AidTM First StrandcDNA Synthesis Kit
(Takara, Dalian, China) according to the manufacturer’s instruc-
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amplification was performed with the following cycling parameters:
denaturation at 94uC for 4 min, followed by 25 cycles (22 cycles for
b-actin) at 94uC for 30 s, 60uC for 40 s, and 72uC for 1 min and
then a single final extension at 72uC for 7 min. Expression of the
target gene was determined by normalizing to the respective b-actin
levels. Each amplification was repeated three times from different
RT reactions, and the data were averaged. The following primers
were used for PCR amplification, based on the cDNA sequence
(GenBank accession number M26744.1, V01217 and AF344185):
IL-6: Forward: 59- TTCACAAGTCCGGAGAGGAG -39; Re-
verse: 59- GAGCATTGGAAGTTGGGGTA -39. b-actin: For-
ward: 59- GGTCACCCACACTGTGCC- CATCTA -39; Reverse:
59- GACCGTCAGGCAGCTCACATAGCTCT -39; Hepcidin:
Forward: 59- CAA GAT GGC ACT AAG CAC TCG -39; Reverse:
59- GCT GGG GTA GGA CAG GAA TAA -39.
Western Blot analysis
Animal brains were perfused with cold saline. Brains were
isolated on ice and homogenized in Lysis buffer (0.5% phenyl
methylsulfonyl fluoride, 0.1% Pepstatin, 0.1% Leupeptin, 0.1%
Aprotinin in TBS-T). After centrifugation at 10,000 g for 30 min at
4uC, the supernatant was collected and protein concentration was
measured with a Pierce BCA protein assay kit (Thermo Scientific,
Rockford, IL, USA). Aliquots of the extract containing 50 mgo f
protein were separated by reducing SDS-PAGE (10% for FPN1,
TfR1, HIF1a and STAT3, 12% for L-ferritin and H-ferritin), and
electroblotted onto nitrocellulose filter membranes for 45 min at
RT. The membranes were blocked in 5% non-fat milk containing
20 mM Tris–HCl, pH 7.6, 137 mM NaCl, 0.1% Tween-20 (TBS-
T) for 2 h at room temperature, and then incubated with antibodies
against L-ferritin (1:5000), H-ferritin (1:2000), FPN1 (1:5000)
(Alpha Diagnostic International, San Antonio, TX), TfR1
(1:2000) (Zymed Laboratories; South San Francisco, CA), HIF-
1a, STAT3, p-STAT3 (1:2000) (Sigma-Aldrich, St. Louis, MO)
overnight at 4uC. After washing with TBS-T three times, the blots
were incubated in secondary-antibody-conjugated horseradish
peroxide (1:5000) (Amersham, UK) for 2 h at room temperature.
Immunoreactive proteins were detected by using the enhanced
chemiluminescence method (ECL kit, Amersham, UK), and
quantified by transmittance densitometry using volume integration
with Gel-Pro software. To ensure even loading of the samples, the
same membrane was probed with rabbit anti-human b-actin
antibody (1:5000) (Sigma-Aldrich, St. Louis, MO).
Immunohistochemistry
For immunohistochemical analysis, animals were anesthetized
with 1% pentobarbital sodium (40 mg/kg body weight, i.p.),
Figure 1. Expression of L-ferritin and H-ferritin in ischemic
brain. Rats were subjected to 60 min MCAO and 24 hour reperfusion.
Contralateral and ipsilateral cerebral cortex (A,E), hippocampus (B,F)
and corpus striatum (C,G) were isolated, homogenized, and analyzed for
L- and H- ferritin by Western blotting. Representative ferritin blots and
corresponding b-actin blots are shown on the top panel. The lower
panel (D, H) shows the summary of L-ferritin and H-ferritin expression
levels from three animals in each group. Results are presented as Mean
6 SEM, n=3. **p,0.01 v.s. contraleteral side, *p,0.05 v.s. contralateral
side.
doi:10.1371/journal.pone.0025324.g001
Figure 2. Expression of FPN1 in ischemic brain. Rats were subjected to 60 min MCAO and 24 hour reperfusion. The expression of FPN1 in the
cerebral cortex (A), hippocampus (B) and corpus striatum (C) of contralateral and ipsilateral side was analyzed by Western blotting. Representative
bands from contralateral side and ipsilateral side are shown on the top panel. The lower panel (D) shows the summary of FPN1 expression from three
animals in each group. The expression of FPN1 was very significantly increased in the ischemic cerebral cortex, corpus striatum at 24 h, and was
significantly increased in the ischemic hippocampus at 24 h. Results are presented as Mean 6 SEM, n=3. **p,0.01 v.s. contraleteral side, *p,0.05 v.s.
contralateral side.
doi:10.1371/journal.pone.0025324.g002
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0.1 mol/L phosphate buffered solution (PB), pH 7.2. Brains were
removed and fixed in 4% paraformaldehyde for 4–6 h at 4uC.
They were then immersed in 30% sucrose in 0.1 mol/L PB
solution for 1–2 days. Serial sections (15 mm) were cut using a
cryostat (Leica CM1900, Germany) and mounted on slides. Prior
to staining, sections were treated with 3% hydrogen peroxide
followed by washing with PB and incubation with 10% normal
goat serum in PB for 1 h at RT. Primary rabbit anti-mouse
hepcidin (1:500 dilution, Alpha Diagnostic International, San
Antonio, TX) was added and incubated overnight at 4uC. After
washed 3 times with PB for 10 min, the brain sections were
incubated with biotinylated goat anti-rabbit secondary antibody
(Zymed Laboratories; South San Francisco, CA, 1:200) for 60 min
at 37uC. After washing, the sections were treated with streptavi-
din–horseradish peroxidase conjugate (1:200 dilution; Zymed
Laboratories) for 60 min at 37uC. The slides were then washed
four times with PB for 5 min and the staining reaction was carried
out using 3,39-diaminobenzidine tetrahydrochloride (DAB) as the
chromogen. Negative controls were processed by replacing the
primary antibody with diluent rabbit serum. The sections were
dehydrated in ethanol, cleared in xylene, and cover-slipped with
neutral balsam. Finally, slices were photographed with Zeiss
Imager A2 microscope (Germany).The same areas were selected
for imaging in cortex, in hippocampus and in corpus striatum. The
photographs were analyzed with the Image-Pro Plus software, and
the AOI was set as the whole image.
The intensity was calibrated with Std. Optical Density (OD).
Manual color was selected (in the count/size column); and the
background Gray Level was set at 150 in all slices, and count 150
to 255 (max) signal in the histogram. Third, the positive Area and
Density (mean) were selected. Finally, we counted the positive area
to get the mean Density.
Statistical Analysis
All quantitative data are presented as mean 6 SEM.
Differences between means in two groups were carried out by
unpaired-samples T-test. A probability value of P,0.05 was
considered to be statistically significant.
Results
Increased ferritin levels in the cerebral cortex,
hippocampus, and corpus striatum
Ferritin is a ubiquitous and highly conserved iron binding
protein, which consists of two subunits (H and L), and it is a major
form of non-heme iron stores in cells. We performed western blot
analyses to determine the ferritin protein levels in different regions
of an ischemic brain. Fig. 1 shows the ferritin levels in cerebral
cortex, hippocampus, and corpus striatum of both control and
ischemia sides. Compared with the control side, the level of L–
ferritin increased significantly in the three regions on the ischemia
side (p ,0.01) (Fig.1D). Similarly, the H-ferritin protein level was
also significantly elevated in the cerebral cortex and the
hippocampus but decreased in the corpus striatum (Fig. 1H) (p
,0.05).
Decreased FPN1 levels in the cerebral cortex,
hippocampus, and corpus striatum
FPN1 is a unique protein involved in iron efflux. Our previous
study elucidated that FPN1 increases iron release in PC12 cells
[23] and primary cultured neurons [23,32]. The present results
demonstrate that FPN1 protein levels in the cerebral cortex
(Fig.2A) and corpus striatum (Fig.2C) significantly decreased in the
ischemia side compared with the control side (p ,0.01) (Fig.2D).
In addition, the expression of FPN1 in the hippocampus (Fig.2B)
Figure 3. mRNA expression of hepcidin in ischemic brain. Rats were subjected to 60 min MCAO and 24 hour reperfusion. RT-PCR analyses
were carried out to evaluate the mRNA level of hepcidin in the cerebral cortex (A), hippocampus (B) and corpus striatum (C) of contralateral and
ipsilateral side. Fig. 3D shows the summary of hepcidin expression from three animals in each group. The expression of hepcidin was significantly
increased in the ischemic cerebral cortex, hippocampus and corpus striatum at 24 h. Results are presented as Mean 6 SEM, n=3. *p,0.05 v.s.
contralateral side.
doi:10.1371/journal.pone.0025324.g003
Ischemia Increases Hepcidin in Rat Brain
PLoS ONE | www.plosone.org 4 September 2011 | Volume 6 | Issue 9 | e25324also decreased significantly in the ischemia side (p ,0.05) (Fig.2D).
These results indicate that ischemia may increase intracellular iron
levels by reducing FPN1 expression.
Increased expression of hepcidin in the cerebral cortex,
hippocampus, and corpus striatum
Hepcidin regulates iron efflux by binding to FPN1 and inducing
its internalization [38]. To investigate the mechanism of FPN1
down-regulation, we examined the mRNA expression of hepcidin
in ischemic brain tissue. The results show that the hepcidin mRNA
level (Fig.3) and hepcidin/pro-hepcidin protein levels (Fig. 4) were
significantly up-regulated in the cerebral cortex, hippocampus,
and corpus striatum of the ischemic hemisphere.
Increased in FPN1 and decreased L-ferritin protein level
by knocking down hepcidin
The above results implied that the up-regulated hepcidin
expression may be an important factor that down-regulates the
FPN1and further increases the iron content inanischemic brain. In
order to confirm the reuslt, we determined the effect of a specific
hepcidin siRNA on the FPN1 and L-ferritin levels. The hepcidin
siRNA treatment increased the FPN1 level in cerebral cortex
(Fig. 5A, p,0.01), hippocampus (Fig. 5B, p,0.05), and corpus
striatum (Fig. 5C, p,0.05) of the ischemic side of the mouse brains.
We next determined the effect of hepcidin siRNA on the L-ferritin
level in the ischemic barin. Results from Western blot analysis
demonstrated that hepcidin siRNA treatment rescued the L-ferritin
increase in the cerebral cortex (Fig. 5A, p,0.05), hippocampus
(Fig. 5B, p,0.01) and corpus striatum (Fig. 5C, p,0.05). The
repressing pattern of L-ferritin was negatively correlated with the
FPN1 increasing pattern. These results further proved that hepcidin
is involved in the iron regulation in the ischemic brain.
Increased Expression of IL-6 in the cerebral cortex,
hippocampus and corpus striatum
The inflammatory cytokine interleukin-6 (IL-6) directly regu-
lates hepcidin through induction and subsequent promoter
binding of signal transducer and activator of transcription 3
(STAT3) [39,40]. STAT3 is necessary and sufficient for the IL-6
responsiveness of the hepcidin promoter[41]. To understand the
mechanism of ischemia-induced upregulation of hepcidin, we
studied both IL-6 protein and mRNA expression (Fig.6). The
expression of IL-6 protein significantly increased in the ipsilateral
cortex, the hippocampus and the corpus striatum (p ,0.05)
(Fig.6D). The mRNA levels of IL-6 were significantly elevated in
the cortex on the ischemic side (p ,0.01 vs. control cortex), the
hippocampus, and the corpus striatum (p ,0.05 vs. the control
hippocampus and corpus striatum) (Fig.6H).
To understand the mechanism of upregulation of hepcidin
caused by brain ischemia, we further examined the expression of
STAT3 and phosphorylated STAT3 (p-STAT3) in the cerebral
cortex (Fig.7A), hippocampus (Fig.7B) and corpus striatum
(Fig.7C). As shown in Fig. 7, the ratio of p-STAT3 to STAT3
on the ischemia side was much higher than on the control side in
the cerebral cortex (p ,0.01), hippocampus (p ,0.01) and corpus
striatum (p ,0.05) (Fig.7D).
Increased TfR1 protein levels in the cerebral cortex and
hippocampus
TfR1 is a key protein that facilitates iron transport into brain
cells. We observed that the TfR1 protein level was dramatically
elevated in the cerebral cortex (Fig. 8A, 8D, p ,0.05) and
hippocampus (Fig.8B, p ,0.01) on the ischemic side (Fig.8D),
compared to their control counterparts. However, there was no
significant change in TfR1 levels in the corpus striatum between
the ischemic and control sides (Fig. 8C and 8D).
Up-regulation of HIF-1a protein in the cerebral cortex,
hippocampus and corpus striatum
HIF-1 is a key regulator in hypoxia, and has been suggested as
an important player in ischemic stroke due to the functions of its
downstream genes that promote glucose metabolism, angiogenesis,
erythropoiesis, and cell survival. In our results, the expression of
HIF-1a in the ischemia side of the cerebral cortex (Fig.9A) was
significantly increased compared with the control side (p ,0.05)
(Fig.9D), and the expression of HIF-1a in the ischemia side of the
hippocampus (Fig.9B) and corpus striatum (Fig.9C) were signifi-
cantly increased compared with the control side (p ,0.01)
(Fig.9D).
Discussion
Ischemic stroke occurs when the blood supply to the brain is
suddenly interrupted by a blood clot blocking a blood vessel in the
Figure 4. Positive hepcidin/pro-hepcidin staining in ischemic
brain. Hepcidin/pro-hepcidin was detected by immunohistochemistry.
Hepcidin/pro-hepcidin positive staining was significantly increased in
cerebral cortex, hippocampus and corpus striatum of ischemic brain.
The mean density of positive staining was measured by Image-Pro Plus
soft. Data are presented as means 6S E M ,n = 3 .* p ,0.05, vs.
contralateral side.
doi:10.1371/journal.pone.0025324.g004
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limited progress in developing effective therapeutic approaches for
ischemic stroke, although numerous agents have been tested in
animal models and in clinical trials. Among many factors,
incomplete understanding of the mechanism responsible for
ischemia-caused neuronal injuries is a major hurdle. Cerebral
ischemia induces a series of molecular pathways involving
signaling mechanisms, gene transcription, and protein modifica-
tion. Free radicals and oxidative stress have been suggested to be
involved in each of the steps in the injury cascade [42]. Iron is the
most important metal element that mediates free radical
generation via a Fenton-type reaction. Furthermore, hypoxia
and free iron appear to interact with each other in causing
subsequent neuronal death [13].
Our present results demonstrate that the iron-storage proteins
L-ferritin and H-ferritin are remarkably elevated in the cerebral
cortex and the hippocampus. Previous studies have shown that
ischemic preconditioning initiates synthesis of ferritin in the heart
[37] and retina [36]. It has been proposed that this increase in
ferritin might protect cells from iron-mediated oxidative damage
during ischemia-reperfusion. Our present data show that L-ferritin
and H-ferritin are increased in ischemic cerebral cortex and
hippocampus (Fig.1), and may provide a mechanism to reduce
iron-mediated injury by reducing free iron. Our results reveal that
both total iron and ferritin-bound iron are significant increased in
the ischemia side of the cerebral cortex and hippocampus (Fig. 10).
Although we cannot conclude that ferritin plays a protective role
based on these results, the increased levels of ferritin indicate that
free iron levels in these tissues should have been reduced by
binding.
Functional studies have demonstrated that hepcidin is the
central regulator of systemic iron homeostasis by regulating FPN1,
the only protein known to release iron from cells [43]. Recently,
data from our laboratory and others have shown that hepcidin is
widely expressed in murine brain and has a very important role in
regulating iron levels in the brain by down-regulating FPN1
Figure 5. Expression of FPN1 and L-ferritin protein levels in the cerebral cortex, hippocampus and corpus striatum of mouse after
hepcidin siRNA injection in the lateral cerebral ventricle. A representative Western blot of the FPN1 and L-ferritin was presented.
Quantification of expression of PFN1 and L-ferritin protein in the cerebral cortex (A), hippocampus (B) and corpus striatum (C) of mouse. Expression
values were normalized for b-actin. The data were presented as means 6 SEM, n=3. *p,0.05, **p,0.01 vs. FPN1 of ischemic side (IS) or control side
(CS), #p,0.05, ##p,0.01 v.s. L-ferritin of ischemic side (IS) or control side (CS). Sham siRNA (negative control treated group), siRNA (specific
hepcidin siRNA treated group).
doi:10.1371/journal.pone.0025324.g005
Figure 6. Expression of IL-6 mRNA and protein in ischemic
brain. Rats were subjected to 60 min MCAO and 24 hour reperfusion.
The IL-6 protein level of cerebral cortex (A), hippocampus (B) and
corpus striatum (C) were analyzed Western blotting. The mRNA level of
cerebral cortex (E), hippocampus (F) and corpus striatum (G) of
contralateral and ipsilateral side was detected by RT-PCR. Fig 4D and
Fig 4H show the summary of IL-6 protein and mRNA expression
respectively. Results are presented as Mean 6 SEM, n=3. **p,0.01 v.s.
contraleteral side, *p,0.05 v.s. contralateral side.
doi:10.1371/journal.pone.0025324.g006
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studied in the ischemic brain. The present study demonstrates that
ischemia-reperfusion increases hepcidin expression and down-
regulates FPN1 protein expression in the cerebral cortex and the
hippocampus. Knockdown hepcidin reversed the FPN1 decrease
and ferritin increase in the ischemic brains of mice. Our present
results demonstrated that down-regulated expression of FPN1 by
hepcidin may be one important mechanism responsible for the
ischemia-induced iron increase in the brain. In other words,
reduced iron release from ischemic brain cells due to down-
regulation of FPN1 increases intracellular iron levels [46].
It is known that inflammation up-regulates hepcidin expression
and that cytokine IL-6 is a major mediator of the inflammatory
response. It has been reported that IL-6 leads to increase in
hepcidin production and decrease in serum iron within a few
hours in humans and experimental animals [39,47]. Previous
studies have revealed the mechanism responsible for IL-6 induced
hepcidin expression [41,48]. Briefly, IL-6 can activate the JAK/
STAT signaling pathway that upregulates the level of p-STAT3.
p-STAT3 binds to the HAMP promoter and thus increases
hepcidin expression. It is well established that inflammation is
involved in stroke and that ischemia increases IL-6 concentrations
in brain tissues. Indeed, in our ischemic model we observed that
cerebral ischemia-reperfusion increased IL-6 production signifi-
cantly. Furthermore, the ratio of p-STAT3/STAT3 in ischemic
tissues was much higher than in control tissues. This implies that
the increased hepcidin in ischemic tissues may be regulated
through the JAK-STAT pathway.
HIF-1 is one of the factors activated in early ischemia that can
induce vascular endothelial growth factor, erythropoietin, etc.
[49]. Those downstream genes of HIF-1 promote cell survival by
generating new blood vessels and providing new oxygen supply
channels. HIF-1 is composed of HIF-1a and HIF-1b protein
subunits. HIF-1b is constitutively expressed and relatively stable.
The HIF-1a level is dependent on tissue oxygen levels and
primarily determines HIF-1 activation. Tang et al. have studied
the relationship between HIF-1a and transferrin. They have
observed that the activation of HIF-1a can induce TfR1
expression, which, in turn, enhances iron accumulation and
eventually increases oxidative damage and lipid peroxidation [50].
Figure 7. Expression of STAT3 in ischemic brain. Rats were subjected to 60 min MCAO and 24 hour reperfusion. Expression of STAT3 in
cerebral cortex (A), hippocampus (B) and corpus striatum (C) was analyzed by Western blotting. D, summary of STAT3 expression in cerebral cortex
hippocampus, and corpus striatum of contralateral and ipsilateral side. Results are presented as Mean 6 SEM, n=3. **p,0.01 v.s. contraleteral side,
*p,0.05 v.s. contralateral side.
doi:10.1371/journal.pone.0025324.g007
Figure 8. Expression of TfR1 in cerebral cortex (A), hippocampus (B) and corpus striatum (C) of contralateral and ipsilateral side by
western blot analysis. Representative TfR blots and corresponding b-actin blots are shown on the top panel. The lower panel (D) shows the
summary of TfR expression from three animals in each group. Results are presented as Mean 6 SEM, n=3. **p,0.01 v.s. contraleteral side, *p,0.05
v.s. contralateral side.
doi:10.1371/journal.pone.0025324.g008
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an iron chelator, can reduce injury caused by cardiac ischemia and
reperfusion [50] and cerebral ischemia [51]. In the present study,
we observed that the HIF-1a expression level is increased in the
ischemic brain, and this result is in agreement with previous
reports [52]. The increased HIF-1a may play a key role in up-
regulating TfR1 expression in the cerebral cortex and hippocam-
pus of the ischemic brain. Thus, the increased TfR1 may be
another pathway by which the iron and ferritin levels are elevated
in ischemic brain cells. The sources of the iron might be
extracellular fluid, which is potentially involved in both intracel-
lular iron storage and intravascular iron transport and delivery to
the brain [9].
Surprisingly, we did not observe increased total iron and H-
ferritin in ischemic corpus striatum. The proportion of total iron
and ferritin-bound iron in ischemic and control areas was different
in the cerebral cortex, the hippocampus, and the corpus striatum
(Fig. 10). These results imply that the ischemia-induced iron
change is region-dependent. The mechanisms of the area-
dependent iron changes are likely complex although the
hepcidin-FPN1 and Tf-TFR pathways may play a role.
In summary, the current observations revealed two pathways
that contribute to iron overload in ischemic brain tissues as
outlined in Figure 11. First, ischemia-reperfusion increases the
expression of IL-6 that up-regulates hepcidin by the JAK/STAT3
pathway. Hepcidin induces FPN1 internalized degradation,
reduces the efflux of iron, and thus causes iron accumulation.
Second, ischemia-reperfusion up-regulates the HIF-1a level,
which upregulates TfR1 expression and accelerates iron accumu-
lation in the ischemic tissues.
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concentrations in brain tissues (per milligram of wet brain tissue). The last two panels of 3 groups represent the ferritin-bound iron (per milligram of
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doi:10.1371/journal.pone.0025324.g010
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